Australia markets closed

China Biologic Products Holdings, Inc. (CBPO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
117.76-0.30 (-0.25%)
At close: 4:00PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 54.54B
Enterprise value 33.55B
Trailing P/E 33.00
Forward P/E 121.97
PEG ratio (5-yr expected) 12.03
Price/sales (ttm)8.83
Price/book (mrq)2.42
Enterprise value/revenue 36.91
Enterprise value/EBITDA 617.04

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 33.30%
S&P500 52-week change 339.88%
52-week high 3120.01
52-week low 397.91
50-day moving average 3118.67
200-day moving average 3115.20

Share statistics

Avg vol (3-month) 3167.69k
Avg vol (10-day) 3142.57k
Shares outstanding 538.58M
Float 13.05M
% held by insiders 145.59%
% held by institutions 150.29%
Shares short (11 Feb 2021) 4978.97k
Short ratio (11 Feb 2021) 45.4
Short % of float (11 Feb 2021) 44.33%
Short % of shares outstanding (11 Feb 2021) 42.52%
Shares short (prior month 14 Jan 2021) 4398.76k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)29 Sep 2020

Profitability

Profit margin 27.42%
Operating margin (ttm)35.25%

Management effectiveness

Return on assets (ttm)5.62%
Return on equity (ttm)8.94%

Income statement

Revenue (ttm)514.4M
Revenue per share (ttm)13.35
Quarterly revenue growth (yoy)1.80%
Gross profit (ttm)329.08M
EBITDA 208.59M
Net income avi to common (ttm)139.37M
Diluted EPS (ttm)3.57
Quarterly earnings growth (yoy)-15.90%

Balance sheet

Total cash (mrq)1.1B
Total cash per share (mrq)28.44
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)12.01
Book value per share (mrq)48.63

Cash flow statement

Operating cash flow (ttm)261.41M
Levered free cash flow (ttm)189.43M